🔎 Trials Near Me

Utama › Penyakit Usus Radang › Tennessee

Kajian klinikal Penyakit Usus Radang di Tennessee

7 kajian untuk Penyakit Usus Radang sedang mencari peserta di lokasi di Tennessee.

Bandar di Tennessee

Teks kajian rasmi (Bahasa Inggeris)

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Cordova
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 017, Kingsport
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-003, Cordova
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07845487

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • Gastrointestinal Associates of Northeast Tennessee, Johnson City
Mengambil pesertaFasa 2
Umur 18 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06226883

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Cordova
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

  • The Vanderbilt Clinic, Nashville
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 24 Okt 2025 · NCT06699121

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • Vanderbilt University, Nashville
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2025 · NCT06750731

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.